GLP-3RT (Retatrutide)
10mg
Triple GIP / GLP-1 / glucagon receptor agonist for metabolic research.
Research Profile
About GLP-3RT (Retatrutide)
Retatrutide (referenced here as GLP-3RT) is a synthetic, long-acting single-molecule peptide engineered to act as a triple agonist across three key metabolic receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon receptor. This simultaneous "triple-G" activity sets it apart from the single- and dual-agonist peptides that preceded it.
Because it recruits all three pathways at once, retatrutide has become a prominent subject of metabolic research, particularly in studies examining energy balance, adiposity, and glucose regulation. It is supplied lyophilized strictly for in-vitro and laboratory research.
Mechanism of Action
The GLP-1 and GIP receptor components are studied for their role in glucose-dependent insulin secretion and satiety signaling, while the glucagon-receptor component is investigated for its influence on hepatic energy metabolism and thermogenesis — a combination thought to drive greater changes in energy expenditure than incretin activity alone.
Research Applications
- Metabolic and energy-expenditure research
- Adiposity and body-composition models
- Glucose homeostasis and insulin signaling
- Comparative incretin-agonist studies
Provided for educational and research context only. GLP-3RT (Retatrutide) is sold strictly for in-vitro laboratory and research use — it is not a drug, supplement, or medical product, is not intended to diagnose, treat, cure, or prevent any disease, and is not for human or veterinary use.
Support
Frequently Asked Questions
Everything you need to know about this product and your order.
